JonesTrading Institutional Services LLC
Third Avenue, 23rd Floor
New York, NY 10017
December 17, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re:
Monopar Therapeutics
Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-233303
Ladies and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as
amended (the “Act”), and as representative of the
several underwriters of the Company’s proposed public
offering, we wish to advise you that we hereby join with the
Company’s request that the effective date of the
above-referenced Registration Statement be accelerated so that the
same will become effective at 4:00PM ET on December 18, 2019, or as
soon thereafter as is practicable.
Pursuant
to Rule 460 under the Act, we wish to advise you that we have
distributed 34 copies of the preliminary prospectus dated December
13, 2019, through the date hereof, to prospective underwriters,
institutional investors, dealers and others.
We,
the undersigned, as representative of the several underwriters,
have complied and will continue to comply, and we have been
informed by the participating underwriters and dealers that they
have complied and will continue to comply, with the requirements of
Rule 15c2-8 under the Securities Exchange Act of 1934, as
amended.
Very
truly yours,
JonesTrading Institutional Services LLC
By:
|
/s/
Burke
Cook
|
Name:
|
Burke
Cook
|
Title:
|
General
Counsel
|